Phreesia (NYSE:PHR) Trading Down 5.9% – Should You Sell?

Phreesia, Inc. (NYSE:PHR)’s share price traded down 5.9% during trading on Tuesday . The stock traded as low as $10.28 and last traded at $10.30. 119,152 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 1,485,985 shares. The stock had previously closed at $10.94.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Robert W. Baird increased their target price on Phreesia from $10.00 to $11.00 and gave the stock a “neutral” rating in a research note on Friday. Needham & Company LLC reaffirmed a “buy” rating and issued a $14.00 price objective on shares of Phreesia in a report on Monday, August 31st. DA Davidson lowered their price objective on Phreesia from $14.00 to $13.00 and set a “buy” rating on the stock in a research report on Friday. Piper Sandler downgraded Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 target price for the company. in a report on Thursday, May 28th. Finally, Weiss Ratings cut shares of Phreesia from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday. Eight research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $14.00.

Phreesia Trading Down 5.4%

The company has a debt-to-equity ratio of 0.33, a current ratio of 1.76 and a quick ratio of 1.76. The business’s 50-day moving average price is $11.26 and its two-hundred day moving average price is $10.46. The company has a market capitalization of $642.42 million, a price-to-earnings ratio of 60.94 and a beta of 0.86.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). Phreesia had a return on equity of 5.22% and a net margin of 2.06%.The company had revenue of $129.46 million for the quarter, compared to analyst estimates of $129.06 million. During the same period in the prior year, the company earned $0.01 EPS. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. Research analysts predict that Phreesia, Inc. will post 0.38 earnings per share for the current year.

Institutional Trading of Phreesia

Several large investors have recently modified their holdings of the stock. Van ECK Associates Corp raised its stake in Phreesia by 78.7% in the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock valued at $42,000 after purchasing an additional 1,102 shares in the last quarter. Rockefeller Capital Management L.P. grew its stake in Phreesia by 354.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after buying an additional 2,149 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in Phreesia by 1,119.8% in the 1st quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock valued at $27,000 after buying an additional 3,001 shares during the period. New York State Teachers Retirement System bought a new position in Phreesia in the 1st quarter valued at about $44,000. Finally, Tower Research Capital LLC TRC increased its holdings in Phreesia by 332.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,610 shares of the company’s stock valued at $160,000 after buying an additional 4,313 shares during the period. 92.10% of the stock is owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.